Transfusion‐related immunomodulation: review of the literature and implications for pediatric critical illness
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Transfusion‐related immunomodulation (TRIM) in the intensive care unit (ICU) is difficult to define and likely represents a complicated set of physiologic responses to transfusion, including both proinflammatory and immunosuppressive effects. Similarly, the immunologic response to critical illness in both adults and children is highly complex and is characterized by both acute inflammation and acquired immune suppression. How transfusion may contribute to or perpetuate these phenotypes in the ICU is poorly understood, despite the fact that transfusion is common in critically ill patients. Both hyperinflammation and severe immune suppression are associated with poor outcomes from critical illness, underscoring the need to understand potential immunologic consequences of blood product transfusion. In this review we outline the dynamic immunologic response to critical illness, provide clinical evidence in support of immunomodulatory effects of blood product transfusion, review preclinical and translational studies to date of TRIM, and provide insight into future research directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400601 · Cited by 5,187 · cited 1×
“Consequently, several prospective randomized controlled trials in adults across a variety of clinical settings have compared restrictive versus liberal transfusion strategies and have demonstrated either improved outcomes in restrictive-group subjects or lack of benefit in the liberally transfused.(29-34) Several meta…”
BackgroundHematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1829 · Cited by 1,781 · cited 2×
“Severe and prolonged lymphopenia, along with lymphocyte apoptosis in lymphoid organs such as the spleen, are strongly associated with adverse outcomes in adult and pediatric sepsis.(17-19) Further, lymphocyte hyporeactivity to ex vivo stimulation, with reduced interferon (IFN)-c production in response to incubation wi…”
BackgroundTransfusion Strategies for Acute Upper Gastrointestinal Bleeding
Villanueva, C., Colomo, A., Bosch, A., Concepción, M., Hernandez-Gea, V., Aracil, C., Graupera, I., Poca, M., Alvarez-Urturi, C., Gordillo, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211801 · Cited by 1,735 · cited 1×
“Consequently, several prospective randomized controlled trials in adults across a variety of clinical settings have compared restrictive versus liberal transfusion strategies and have demonstrated either improved outcomes in restrictive-group subjects or lack of benefit in the liberally transfused.(29-34) Several meta…”
BackgroundLiberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery
Carson, J. L., Terrin, M. L., Noveck, H., Sanders, D. W., Chaitman, B. R., Rhoads, G. G., Nemo, G., Dragert, K., Beaupre, L., Hildebrand, K., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012452 · Cited by 1,328 · cited 1×
“Consequently, several prospective randomized controlled trials in adults across a variety of clinical settings have compared restrictive versus liberal transfusion strategies and have demonstrated either improved outcomes in restrictive-group subjects or lack of benefit in the liberally transfused.(29-34) Several meta…”
BackgroundMonocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Transfusion Strategies for Patients in Pediatric Intensive Care Units
Lacroix, J., Hébert, P. C., Hutchison, J. S., Hume, H. A., Tucci, M., Ducruet, T., Gauvin, F., Collet, J.-P., Toledano, B. J., Robillard, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066240 · Cited by 1,085 · cited 2×
“In 2007 Lacroix and coworkers(41) published a prospective randomized controlled trial of transfusion strategies in pediatric critically ill patients that demonstrated that a restrictive transfusion strategy decreased RBC transfusions without increasing the incidence of new or progressive MODS.(41) Subgroup analyses fr…”
ResultSelf-citationRed Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
Carson, J. L., Grossman, B. J., Kleinman, S., Tinmouth, A. T., Marques, M. B., Fung, M. K., Holcomb, J. B., Illoh, O., Kaplan, L. J., Katz, L. M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-1-201206190-00429 · Cited by 1,084 · cited 1×
“appears to be safe in most settings, with no obvious benefit to liberal transfusion practices.(35-38) Similar to adult studies, retrospective studies in critically ill children identify RBC transfusion as an independent risk factor for morbidity and mortality.”
BackgroundTransfusion Requirements After Cardiac Surgery: The TRACS Randomized Controlled Trial
Hajjar, L. A., Vincent, J.-L., Galas, F. R. B. G., Nakamura, R. E., Silva, C. M. P., Santos, M. H., Fukushima, J., Filho, R. K., Sierra, D. B., Lopes, N. H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1446 · Cited by 1,054 · cited 1×
“Consequently, several prospective randomized controlled trials in adults across a variety of clinical settings have compared restrictive versus liberal transfusion strategies and have demonstrated either improved outcomes in restrictive-group subjects or lack of benefit in the liberally transfused.(29-34) Several meta…”
Background
Cited by
Mechanisms of red blood cell transfusion‐related immunomodulation
Remy, K. E., Hall, M. W., Cholette, J., Juffermans, N. P., Nicol, K., Doctor, A., Blumberg, N., Spinella, P. C., Norris, P. J., Dahmer, M. K., et al. (2018) · Transfusion · doi:10.1111/trf.14488 · Cited by 245
“Indeed, mixed immunomodulatory potential of RBC transfusion may be particularly relevant for critically ill patients in whom both excess inflammation and immune suppression are significantly associated with adverse outcomes.(14) Overall, defining the sum total immunomodulatory effects of particular RBC products in ind…”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Muszynski, J. A., Spinella, P. C., Cholette, J. M., Acker, J. P., Hall, M. W., Juffermans, N. P., Kelly, D. P., Blumberg, N., Nicol, K., Liedel, J., Doctor, A., Remy, K. E., Tucci, M., Lacroix, J., Norris, P. J., & for the Pediatric Critical Care Blood Research Network (Blood Net)
- Venue
- Transfusion
- Publisher
- Wiley
- Published
- 2016-10-02
- Volume
- 57
- Issue
- 1
- Pages
- 195-206
- ISSN
- 0041-1132 (ISSN-L)
- 1537-2995
- OpenAlex
- W2528954978
- Cited by
- 158
- References
- 99
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.